Sirolimus Market: Increase in Incidence of Target Diseases to Drive the Market
A prophylaxis of rejection, sirolimus is critical in treatment for chronic allograft dysfunction, and refractory acute rejection. Besides, it is now also considered a powerful immunosuppressant. And, this can be transformative as it is supposedly better than available alternatives.
View full press release